Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.88 Consensus Price Target from Brokerages

Privia Health Group, Inc. (NASDAQ:PRVA) has earned an average recommendation of “Buy” from the eighteen research firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, fourteen have issued a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $24.88.

Several brokerages have commented on PRVA. Needham & Company LLC initiated coverage on shares of Privia Health Group in a report on Friday. They issued a “buy” rating and a $25.00 price objective for the company. JPMorgan Chase & Co. lifted their price objective on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. KeyCorp assumed coverage on Privia Health Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price for the company. Macquarie began coverage on Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 target price for the company. Finally, Stephens reiterated an “overweight” rating and issued a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. FMR LLC grew its position in Privia Health Group by 1.5% in the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after purchasing an additional 271,645 shares during the period. Geode Capital Management LLC increased its position in Privia Health Group by 1.0% during the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock valued at $43,986,000 after acquiring an additional 23,178 shares during the last quarter. Franklin Resources Inc. lifted its holdings in Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after acquiring an additional 28,480 shares during the period. Millennium Management LLC grew its stake in shares of Privia Health Group by 2,994.2% during the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock valued at $19,788,000 after purchasing an additional 1,101,730 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in shares of Privia Health Group by 18.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock valued at $19,441,000 after purchasing an additional 173,934 shares during the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Price Performance

Shares of Privia Health Group stock opened at $20.51 on Wednesday. The stock has a market capitalization of $2.46 billion, a P/E ratio of 205.12, a price-to-earnings-growth ratio of 5.45 and a beta of 0.85. Privia Health Group has a one year low of $15.92 and a one year high of $23.24. The business’s 50 day simple moving average is $20.93 and its two-hundred day simple moving average is $19.43.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.